Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $80,566.24 +0.92%
Ethereum $2,255.64 -0.45%
BNB $685.76 +1.92%
Optimism $0.14 -3.43%
Arbitrum $0.13 -1.51%
Solana $91.15 +0.09%
Polygon $0.22 +2.77%
Cosmos $2.01 -0.18%
Avalanche $9.78 +0.83%

Bitcoin $80,566.24 +0.92%
Ethereum $2,255.64 -0.45%
BNB $685.76 +1.92%
Optimism $0.14 -3.43%
Arbitrum $0.13 -1.51%
Solana $91.15 +0.09%
Polygon $0.22 +2.77%
Cosmos $2.01 -0.18%
Avalanche $9.78 +0.83%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B